Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 1 hour 7 min ago

Roche’s risdiplam hits targets in SMA trial

11/11/2019
The results are from the largest placebo-controlled study ever undertaken in type I or III SMA patients.

Horizon divests animal models business to Envigo

11/11/2019
The agreement is expected to be completed within 30-45 days.

Bavencio falls at late-stage hurdle

11/11/2019
Topline results showed that the drug didn't meet the primary endpoints of superior overall survival, compared with standard of care.

NICE U-turn for Epidyolex in epilepsy

11/11/2019
Despite the good news, there is still “disappointment surrounding the restrictions on prescribing cannabis-based drugs in the UK."

Roxadustat hits efficacy, CV targets in CKD-related anaemia

11/11/2019
The data marks an important milestone for CKD-related anaemia patients, as it is the "first innovation of its kind for this market in many years.”

ObsEva ditches IVF trial after disappointing late-stage results

08/11/2019
The treatment fell short of its primary endpoint of increase in ongoing pregnancy rate at 10 weeks.

MSD recruits Promega for Keytuda companion diagnostic

08/11/2019
Keytruda is predicted to be the best-selling drug by annual revenue in 2023.

J&J submits EMA applications for Ebola vaccine

08/11/2019
The MAAs are supported by data from Phase I, II and III clinical studies.

Owlstone, Thermo Fisher team up for early disease detection

08/11/2019
If successful, Thermo's mass analyser will become a standard part of Owlstone Medical’s biomarker discovery process.

PredictImmune announces PredictSURE IBD study

07/11/2019
The jointly-sponsored study aims to validate PredictSURE IBD – the company’s first prognostic test for inflammatory bowel disease, in the US market.

EMA validates Bratovi, Mektovi application for some mCRC

07/11/2019
Currently, there are limited treatment options available that can prolong the lives of metastatic colorectal cancer patients.

Bemcentinib, Keytruda combo hits endpoints in mid-stage NSCLC trial

07/11/2019
Bemcentinib, formerly known as BGB324, is a potentially first-in-class selective AXL inhibitor.

Vifor Pharma, Evotec venture in to nephrology therapeutics

07/11/2019
The partnership will enable Vifor to identify new targets for renal therapies to bolster the company's pipeline.

First national medical cannabis registry launched

07/11/2019
Despite the legislation of cannabis being passed a year ago, it remains out of reach for the vast majority of patients.

FDA grants Sandoz approval for Ziextenzo in oncology care

06/11/2019
The drug has been approved and marketed in Europe as Ziextenzo since 2018.

The return of NICE international

06/11/2019
The initiative provides support in developing systems to improve health and social care evidence-based decision making.

NHS reveals online training for speedier hospital dismissal

06/11/2019
The new platform is called ActNow, and people "get back to the comfort of their own home quicker."

AZ launch new medicine research, development centres in China

06/11/2019
The Global R&D Centre will carry out R&D for potential new innovative medicines, and more than double AstraZeneca’s Shanghai R&D headcount to around 1,000.

Mission Bio launches Tapestri Platform to identify accurate cancer targets

06/11/2019
The technology is the first-of-its-kind, detecting DNA and protein changes simultaneously.

Awards evening approaching for the Communications Team of the Year, Marketer and Sales Awards

06/11/2019
The awards ceremony for the 2019 competition’s will be taking place on the 14th November at the Chelsea Harbour Hotel.

Pages

X